BRCA2 and cancer: At which extend a cancer predisposing protein truncating mutation (e.g., in BRCA1 or BRCA2) will impair DNA surveillance complexes can also depend on the presence of particular polymorphic forms in other proteins participating in the same complexes (called modifier genes in this case).